Latest Leverage News

Bass Oil Limited reported a 3% rise in September oil production, driven by a 20% uplift in Indonesian output, while awaiting regulatory approval for a strategic gas field acquisition.

Tasman Resources has raised $2 million through a two-tranche placement to fund a promising drilling campaign at Parkinson Dam and broaden its project portfolio, alongside appointing a new director to steer its strategic ambitions.

Charger Metals has initiated a 3,000m drilling program at its Lake Johnston Lithium and Gold Project, fully funded by Rio Tinto Exploration, targeting multiple high-priority lithium and gold prospects. This follows a recent maiden resource estimate and aims to unlock further potential in a prolific Western Australian region.

Lithium Universe Limited has raised $2.5 million through a placement to advance its lithium refinery in Québec and innovative solar panel recycling technology. The funding highlights investor confidence in the company’s dual strategy to close North America’s lithium supply gap and pioneer sustainable metal recovery.

Victory Metals reports substantial grade increases in terbium, dysprosium, and scandium at its North Stanmore Project, leveraging a simple beneficiation method that enhances strategic supply prospects amid tightening Chinese export controls.

Findi Limited updates FY26 guidance with over A$100 million revenue forecast, announces acquisition of Sphere loyalty platform, and advances IPO plans on Bombay Stock Exchange.

Central Petroleum has secured a new 1.3 petajoule gas supply agreement with McArthur River Mining, enhancing cash flow certainty through fixed pricing and take-or-pay terms.

Dart Mining continues to reveal promising antimony mineralisation at its Coonambula project in Queensland, aligning with the new Australia-USA critical minerals pact. Assay results are pending, but visual drilling intercepts suggest significant potential.

CONNEQT Health reports robust sales momentum for its CONNEQT Pulse arterial health monitor, with quarterly sales growth exceeding 50% and a fresh order for 10,000 units to meet rising demand.

PYC Therapeutics has kicked off a global Phase 1b repeat dose study of its investigational drug PYC-001 targeting Autosomal Dominant Optic Atrophy, a rare genetic eye disease with no current treatments. Initial dosing has begun, with key data expected in the second half of 2026.

Pure Hydrogen Corporation has locked in a $2.5 million loan facility to accelerate its clean energy vehicle rollout, aiming to capitalise on a growing sales pipeline in Australia and the US.

Judo Capital Holdings Limited reported strong FY25 results with significant lending growth and profit increases, while expanding its SME banking footprint and advancing technology. The bank sets confident FY26 guidance amid strategic board changes.